Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Merit Cudkowicz
Jeremy Shefner

Showing results (31-40 of 154) with videos related to

Pageof 16
Sort By:
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 24, 2019
ALS/SURV: a modification of the CAFS statisticStephen A Goutman, Morton B Brown, Merit Cudkowicz, et al.
Muscle & Nerve|February 7, 2026
Study 19 (MCI186-19) Post Hoc AnalysesBenjamin Rix Brooks, Jeremy Shefner, Stephen Apple
Nature Reviews. Neurology|October 13, 2011
Biomarkers in amyotrophic lateral sclerosis: opportunities and limitationsRobert Bowser, Martin R Turner, Jeremy Shefner
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|December 7, 2010
Proposed BioRepository platform solution for the ALS research communityAlex Sherman, Robert Bowser, Daniela Grasso, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 5, 2023
Effect of sodium phenylbutyrate and taurursodiol on plasma concentrations of neuroinflammatory biomarkers in amyotrophic lateral sclerosis: results from the CENTAUR trialRobert Bowser, Jiyan An, Lahar Mehta, et al.
Annals of Clinical and Translational Neurology|October 9, 2023
Analysis of sodium phenylbutyrate and taurursodiol survival effect in ALS using external controlsSabrina Paganoni, Melanie Quintana, Alexander V Sherman, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|November 25, 2010
Depression in amyotrophic lateral sclerosisNazem Atassi, Amanda Cook, Cristiana M E Pineda, et al.
Neurology|January 26, 2018
Randomized, double-blind, placebo-controlled trial of arimoclomol in rapidly progressive <i>SOD1</i> ALSMichael Benatar, Joanne Wuu, Peter M Andersen, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 2, 2014
Diagnostic timelines and delays in diagnosing amyotrophic lateral sclerosis (ALS)Sabrina Paganoni, Eric A Macklin, Alexandra Lee, et al.
Neurology|July 8, 2016
Quantitative strength testing in ALS clinical trialsJeremy M Shefner, Dawei Liu, Melanie L Leitner, et al.
Pageof 16

Showing results (31-40 of 154) with videos related to

Sort By:
Pageof 16
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 24, 2019
ALS/SURV: a modification of the CAFS statisticStephen A Goutman, Morton B Brown, Merit Cudkowicz, et al.
Muscle & Nerve|February 7, 2026
Study 19 (MCI186-19) Post Hoc AnalysesBenjamin Rix Brooks, Jeremy Shefner, Stephen Apple
Nature Reviews. Neurology|October 13, 2011
Biomarkers in amyotrophic lateral sclerosis: opportunities and limitationsRobert Bowser, Martin R Turner, Jeremy Shefner
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|December 7, 2010
Proposed BioRepository platform solution for the ALS research communityAlex Sherman, Robert Bowser, Daniela Grasso, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 5, 2023
Effect of sodium phenylbutyrate and taurursodiol on plasma concentrations of neuroinflammatory biomarkers in amyotrophic lateral sclerosis: results from the CENTAUR trialRobert Bowser, Jiyan An, Lahar Mehta, et al.
Annals of Clinical and Translational Neurology|October 9, 2023
Analysis of sodium phenylbutyrate and taurursodiol survival effect in ALS using external controlsSabrina Paganoni, Melanie Quintana, Alexander V Sherman, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|November 25, 2010
Depression in amyotrophic lateral sclerosisNazem Atassi, Amanda Cook, Cristiana M E Pineda, et al.
Neurology|January 26, 2018
Randomized, double-blind, placebo-controlled trial of arimoclomol in rapidly progressive <i>SOD1</i> ALSMichael Benatar, Joanne Wuu, Peter M Andersen, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 2, 2014
Diagnostic timelines and delays in diagnosing amyotrophic lateral sclerosis (ALS)Sabrina Paganoni, Eric A Macklin, Alexandra Lee, et al.
Neurology|July 8, 2016
Quantitative strength testing in ALS clinical trialsJeremy M Shefner, Dawei Liu, Melanie L Leitner, et al.
Pageof 16